Sleep Aids Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global sleep aids market is poised for steady growth, with its value projected to increase from $29.48 billion in 2024 to $40.15 billion by 2031, reflecting a CAGR of 4.50%. With an increasing demand for effective sleep products, the market is poised for significant expansion, addressing the needs of a wide range of consumers who are recognizing sleep as a vital aspect of overall health and wellness.

Soaring Demand for Sleep Solutions Spurs Market Expansion

The global sleep aids market is experiencing a notable surge in demand, particularly for products such as mattresses, pillows, chin straps, and nasal devices. These items have gained widespread popularity due to their easy availability and proven effectiveness in enhancing sleep quality. As more individuals become conscious of the benefits of sound sleep, the adoption of these aids continues to grow, contributing substantially to the market's expansion.

Consumers are placing increasing emphasis on their sleep health, and this shift is evident in their willingness to invest in products that promote better sleep. From luxurious mattresses to cutting-edge sleep accessories, the market is catering to a diverse array of consumer needs, further fueling its growth. The availability of these products on e-commerce platforms has also been instrumental in making them accessible to a wider audience, thus accelerating market growth.

Innovations in Sleep Monitoring and Engineering

The integration of digital technologies, particularly the Internet of Things (IoT), is transforming the way sleep disorders are monitored and treated. Wearable devices and advanced sleep engineering systems are becoming increasingly sophisticated, offering consumers new methods to track and improve their sleep quality. These technologies are beneficial not only for individuals with sleep disorders but also for the general population seeking to enhance their sleep experience.

Wearable sleep monitors, for instance, have evolved to provide detailed insights into sleep patterns, including efficiency, stages, and potential disorders. These devices utilize advanced sensors and algorithms to monitor sleep-related metrics, offering users a comprehensive understanding of their sleep health. The rise of digital therapeutics (DTx) is also noteworthy, as these technologies aim to address and even cure sleep-related issues through innovative, non-invasive approaches.

The growing interest in sleep as a critical component of overall well-being has bolstered the demand for digital sleep aids. As consumers become more aware of the importance of sleep, they are increasingly turning to digital solutions that offer convenience and personalized insights. This trend is expected to continue driving the market forward as more consumers seek out innovative sleep technologies.

Safety Concerns and Challenges of Digital Therapeutics

While the sleep aids market is positioned for growth, it faces certain challenges. The use of pharmacological treatments for sleep disorders, for instance, often comes with various side effects. Over-the-counter sleep aids, which frequently contain antihistamines, can cause adverse reactions such as dry mouth, dizziness, constipation, and blurred vision. Additionally, the long-term use of these medications can lead to dependency and other health complications.

The limitations of digital therapeutics also present challenges to the market's growth. While these technologies offer convenience and accessibility, they are often criticized for their lack of personalization and the high dropout rates associated with digital cognitive behavioral therapy (CBT). The absence of direct support from a therapist can make it difficult for users to remain engaged with the treatment, especially if they do not see immediate improvements in their sleep.

Moreover, some prescribed sleeping pills are associated with parasomnia, a disruptive sleep disorder that can cause individuals to engage in dangerous behaviors while still asleep. Patients taking certain medications, such as Z-drugs, may experience sleepwalking, sleep-eating, or even sleep-driving without being aware of their actions. These safety concerns highlight the ongoing need for innovation in the development of safer and more effective sleep aids.

United States: A Leading Market for Sleep Aids

The United States remains a dominant player in the North American sleep aids market. The prevalence of sleep disorders in the U.S. is particularly high, driven by factors such as increased alcohol and tobacco consumption, as well as rising levels of stress and anxiety. The presence of major market players in the region, coupled with growing consumer awareness about the benefits of sleep aids, is contributing to the market's robust performance.

The U.S. market is also benefiting from the increasing adoption of devices like CPAP (Continuous Positive Airway Pressure) and BiPAP (Bilevel Positive Airway Pressure) machines, which are commonly used to treat sleep apnea and other chronic lung conditions. As the population ages and disposable incomes rise, the demand for these devices is expected to grow, further strengthening the market.

Germany: A Key Player in the European Market

Germany is emerging as a significant force in the European sleep aids market, driven by a growing awareness of sleep disorders and an aging population. Organizations such as the British Sleep Society and the Survey Sleep Research Center are actively working to raise awareness about the risks associated with poor sleep, leading to increased demand for sleep aids in the region.

The aging population in Europe, particularly in Germany, is a significant factor driving market growth. As more people enter their senior years, the prevalence of sleep disorders such as insomnia and sleep apnea is expected to rise. This demographic trend is likely to fuel demand for sleep aids, particularly those designed to meet the unique needs of older adults.

China: An Emerging Market for Sleep Aids

China is quickly becoming a key market for sleep aids, driven by lifestyle changes and a growing awareness of the importance of sleep health. The younger population in China is increasingly investing in high-quality sleep products, including luxury mattresses, bedding, and innovative sleep accessories. This trend reflects a broader shift towards prioritizing wellness and self-care.

As public awareness of sleep disorders increases, more people in China are seeking out sleep aids to improve their sleep quality. The market is also benefiting from rising per capita income and a growing middle class that is willing to spend on premium sleep products. This shift in consumer behavior is expected to contribute significantly to the growth of the sleep aids market in the Asia-Pacific region.

Competitive Analysis

ResMed Inc.
Koninklijke Philips N.V.
Merck & Co. Inc.
Drive DeVilbiss Healthcare LLC
GlaxoSmithKline Plc.
Fisher & Paykel Healthcare Limited
Sanofi SA
Pfizer Inc

Key Segments Covered in Global Industry Research

Product:

Drugs
- oInsomnia Treatment Drugs
Doxepin Hydrochloride
Eszopiclone
Ramelteon
Triazolam
Zaleplon
Quazepam
Others
- oNarcolepsy Treatment Drugs
Modafinil
Sodium Oxybate
Armodafinil
Others
Devices
- oCPAP Devices
- oBiPAP Devices
- oAPAP Devices
Others
- oMattresses and Pillows
- oChin Straps
- oMouth Pieces and Nasal Devices

Indication:

Insomnia
Sleep Deprivation
Narcolepsy
Sleep Apnea
Others

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
e commerce
Drug Stores
Others

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Sleep Aids Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Sleep Aids Market Outlook, 2019 - 2031

3.1. Global Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Drugs
    - 3.1.1.1.1. Insomnia Treatment Drugs
      - 3.1.1.1.1.1. Doxepin Hydrochloride
      - 3.1.1.1.1.2. Eszopiclone
      - 3.1.1.1.1.3. Ramelteon
      - 3.1.1.1.1.4. Triazolam
      - 3.1.1.1.1.5. Zalepion
      - 3.1.1.1.1.6. Quazepam
      - 3.1.1.1.1.7. Others
    - 3.1.1.1.2. Narcolepsy Treatment Drugs
      - 3.1.1.1.2.1. Modafinil
      - 3.1.1.1.2.2. Sodium Oxybate
      - 3.1.1.1.2.3. Armodafinil
      - 3.1.1.1.2.4. Others
  - 3.1.1.2. Devices
    - 3.1.1.2.1. CPAP Devices
    - 3.1.1.2.2. BIPAP Devices
    - 3.1.1.2.3. APAP Devices
  - 3.1.1.3. Others
    - 3.1.1.3.1. Mattresses and Pillows
    - 3.1.1.3.2. Chin Straps
    - 3.1.1.3.3. Mouth Pieces and Nasal Devices
3.2. Global Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Insomnia
  - 3.2.1.2. Sleep Deprivation
  - 3.2.1.3. Narcolepsy
  - 3.2.1.4. Sleep Apnea
  - 3.2.1.5. Others
3.3. Global Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Hospital Pharmacies
  - 3.3.1.2. Retail Pharmacies
  - 3.3.1.3. e commerce
  - 3.3.1.4. Drug Stores
  - 3.3.1.5. Others
3.4. Global Sleep Aids Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Sleep Aids Market Outlook, 2019 - 2031

4.1. North America Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Drugs
    - 4.1.1.1.1. Insomnia Treatment Drugs
      - 4.1.1.1.1.1. Doxepin Hydrochloride
      - 4.1.1.1.1.2. Eszopiclone
      - 4.1.1.1.1.3. Ramelteon
      - 4.1.1.1.1.4. Triazolam
      - 4.1.1.1.1.5. Zalepion
      - 4.1.1.1.1.6. Quazepam
      - 4.1.1.1.1.7. Others
    - 4.1.1.1.2. Narcolepsy Treatment Drugs
      - 4.1.1.1.2.1. Modafinil
      - 4.1.1.1.2.2. Sodium Oxybate
      - 4.1.1.1.2.3. Armodafinil
      - 4.1.1.1.2.4. Others
  - 4.1.1.2. Devices
    - 4.1.1.2.1. CPAP Devices
    - 4.1.1.2.2. BIPAP Devices
    - 4.1.1.2.3. APAP Devices
  - 4.1.1.3. Others
    - 4.1.1.3.1. Mattresses and Pillows
    - 4.1.1.3.2. Chin Straps
    - 4.1.1.3.3. Mouth Pieces and Nasal Devices
4.2. North America Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Insomnia
  - 4.2.1.2. Sleep Deprivation
  - 4.2.1.3. Narcolepsy
  - 4.2.1.4. Sleep Apnea
  - 4.2.1.5. Others
4.3. North America Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospital Pharmacies
  - 4.3.1.2. Retail Pharmacies
  - 4.3.1.3. e commerce
  - 4.3.1.4. Drug Stores
  - 4.3.1.5. Others
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 4.4.1.2. U.S. Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 4.4.1.3. U.S. Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 4.4.1.4. Canada Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 4.4.1.5. Canada Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 4.4.1.6. Canada Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Sleep Aids Market Outlook, 2019 - 2031

5.1. Europe Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Drugs
    - 5.1.1.1.1. Insomnia Treatment Drugs
      - 5.1.1.1.1.1. Doxepin Hydrochloride
      - 5.1.1.1.1.2. Eszopiclone
      - 5.1.1.1.1.3. Ramelteon
      - 5.1.1.1.1.4. Triazolam
      - 5.1.1.1.1.5. Zalepion
      - 5.1.1.1.1.6. Quazepam
      - 5.1.1.1.1.7. Others
    - 5.1.1.1.2. Narcolepsy Treatment Drugs
      - 5.1.1.1.2.1. Modafinil
      - 5.1.1.1.2.2. Sodium Oxybate
      - 5.1.1.1.2.3. Armodafinil
      - 5.1.1.1.2.4. Others
  - 5.1.1.2. Devices
    - 5.1.1.2.1. CPAP Devices
    - 5.1.1.2.2. BIPAP Devices
    - 5.1.1.2.3. APAP Devices
  - 5.1.1.3. Others
    - 5.1.1.3.1. Mattresses and Pillows
    - 5.1.1.3.2. Chin Straps
    - 5.1.1.3.3. Mouth Pieces and Nasal Devices
5.2. Europe Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Insomnia
  - 5.2.1.2. Sleep Deprivation
  - 5.2.1.3. Narcolepsy
  - 5.2.1.4. Sleep Apnea
  - 5.2.1.5. Others
5.3. Europe Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospital Pharmacies
  - 5.3.1.2. Retail Pharmacies
  - 5.3.1.3. e commerce
  - 5.3.1.4. Drug Stores
  - 5.3.1.5. Others
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.2. Germany Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 5.4.1.3. Germany Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.4. U.K. Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.5. U.K. Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 5.4.1.6. U.K. Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.7. France Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.8. France Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 5.4.1.9. France Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.10. Italy Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.11. Italy Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 5.4.1.12. Italy Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.13. Turkey Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.14. Turkey Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 5.4.1.15. Turkey Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.16. Russia Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.17. Russia Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 5.4.1.18. Russia Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.19. Rest of Europe Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.20. Rest of Europe Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 5.4.1.21. Rest of Europe Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cassava Starch Market Outlook, 2019 - 2031

6.1. Asia Pacific Cassava Starch Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Drugs
    - 6.1.1.1.1. Insomnia Treatment Drugs
      - 6.1.1.1.1.1. Doxepin Hydrochloride
      - 6.1.1.1.1.2. Eszopiclone
      - 6.1.1.1.1.3. Ramelteon
      - 6.1.1.1.1.4. Triazolam
      - 6.1.1.1.1.5. Zalepion
      - 6.1.1.1.1.6. Quazepam
      - 6.1.1.1.1.7. Others
    - 6.1.1.1.2. Narcolepsy Treatment Drugs
      - 6.1.1.1.2.1. Modafinil
      - 6.1.1.1.2.2. Sodium Oxybate
      - 6.1.1.1.2.3. Armodafinil
      - 6.1.1.1.2.4. Others
  - 6.1.1.2. Devices
    - 6.1.1.2.1. CPAP Devices
    - 6.1.1.2.2. BIPAP Devices
    - 6.1.1.2.3. APAP Devices
  - 6.1.1.3. Others
    - 6.1.1.3.1. Mattresses and Pillows
    - 6.1.1.3.2. Chin Straps
    - 6.1.1.3.3. Mouth Pieces and Nasal Devices
6.2. Asia Pacific Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Insomnia
  - 6.2.1.2. Sleep Deprivation
  - 6.2.1.3. Narcolepsy
  - 6.2.1.4. Sleep Apnea
  - 6.2.1.5. Others
6.3. Asia Pacific Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospital Pharmacies
  - 6.3.1.2. Retail Pharmacies
  - 6.3.1.3. e commerce
  - 6.3.1.4. Drug Stores
  - 6.3.1.5. Others
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.2. China Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 6.4.1.3. China Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.4. Japan Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.5. Japan Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 6.4.1.6. Japan Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.7. South Korea Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.8. South Korea Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 6.4.1.9. South Korea Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.10. India Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.11. India Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 6.4.1.12. India Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.13. Southeast Asia Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.14. Southeast Asia Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 6.4.1.15. Southeast Asia Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.16. Rest of Asia Pacific Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.17. Rest of Asia Pacific Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 6.4.1.18. Rest of Asia Pacific Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Sleep Aids Market Outlook, 2019 - 2031

7.1. Latin America Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Drugs
    - 7.1.1.1.1. Insomnia Treatment Drugs
      - 7.1.1.1.1.1. Doxepin Hydrochloride
      - 7.1.1.1.1.2. Eszopiclone
      - 7.1.1.1.1.3. Ramelteon
      - 7.1.1.1.1.4. Triazolam
      - 7.1.1.1.1.5. Zalepion
      - 7.1.1.1.1.6. Quazepam
      - 7.1.1.1.1.7. Others
    - 7.1.1.1.2. Narcolepsy Treatment Drugs
      - 7.1.1.1.2.1. Modafinil
      - 7.1.1.1.2.2. Sodium Oxybate
      - 7.1.1.1.2.3. Armodafinil
      - 7.1.1.1.2.4. Others
  - 7.1.1.2. Devices
    - 7.1.1.2.1. CPAP Devices
    - 7.1.1.2.2. BIPAP Devices
    - 7.1.1.2.3. APAP Devices
  - 7.1.1.3. Others
    - 7.1.1.3.1. Mattresses and Pillows
    - 7.1.1.3.2. Chin Straps
    - 7.1.1.3.3. Mouth Pieces and Nasal Devices
7.2. Latin America Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
7.3. Latin America Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospital Pharmacies
  - 7.3.1.2. Retail Pharmacies
  - 7.3.1.3. e commerce
  - 7.3.1.4. Drug Stores
  - 7.3.1.5. Others
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.2. Brazil Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 7.4.1.3. Brazil Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 7.4.1.4. Mexico Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.5. Mexico Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 7.4.1.6. Mexico Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 7.4.1.7. Argentina Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.8. Argentina Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 7.4.1.9. Argentina Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 7.4.1.10. Rest of Latin America Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.11. Rest of Latin America Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 7.4.1.12. Rest of Latin America Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Sleep Aids Market Outlook, 2019 - 2031

8.1. Middle East & Africa Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Drugs
    - 8.1.1.1.1. Insomnia Treatment Drugs
      - 8.1.1.1.1.1. Doxepin Hydrochloride
      - 8.1.1.1.1.2. Eszopiclone
      - 8.1.1.1.1.3. Ramelteon
      - 8.1.1.1.1.4. Triazolam
      - 8.1.1.1.1.5. Zalepion
      - 8.1.1.1.1.6. Quazepam
      - 8.1.1.1.1.7. Others
    - 8.1.1.1.2. Narcolepsy Treatment Drugs
      - 8.1.1.1.2.1. Modafinil
      - 8.1.1.1.2.2. Sodium Oxybate
      - 8.1.1.1.2.3. Armodafinil
      - 8.1.1.1.2.4. Others
  - 8.1.1.2. Devices
    - 8.1.1.2.1. CPAP Devices
    - 8.1.1.2.2. BIPAP Devices
    - 8.1.1.2.3. APAP Devices
  - 8.1.1.3. Others
    - 8.1.1.3.1. Mattresses and Pillows
    - 8.1.1.3.2. Chin Straps
    - 8.1.1.3.3. Mouth Pieces and Nasal Devices
8.2. Middle East & Africa Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Insomnia
  - 8.2.1.2. Sleep Deprivation
  - 8.2.1.3. Narcolepsy
  - 8.2.1.4. Sleep Apnea
  - 8.2.1.5. Others
8.3. Middle East & Africa Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.2. GCC Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 8.4.1.3. GCC Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 8.4.1.4. South Africa Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.5. South Africa Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 8.4.1.6. South Africa Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 8.4.1.7. Egypt Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.8. Egypt Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 8.4.1.9. Egypt Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 8.4.1.10. Nigeria Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.11. Nigeria Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 8.4.1.12. Nigeria Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Distribution Channel vs by Indication Heat map
9.2. Manufacturer vs by Indication Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. ResMed Inc.
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Koninklijke Philips N.V.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Merck & Co. Inc.
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Drive DeVilbiss Healthcare LLC
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. GlaxoSmithKline Pic.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Fisher & Paykel Healthcare Limited
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Sanofi SA
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Pfizer Inc
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations